Transcription of Procedure under Article 5(3) of Regulation EC (No) 726 ...
{{id}} {{{paragraph}}}
Official address Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands An agency of the European Union Address for visits and deliveries Refer to Send us a question Go to Telephone +31 (0)88 781 6000 European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged. 25 June 2020 EMA/369136/2020 Committee for medicinal Products for human Use (CHMP) Assessment report Procedure under Article 5(3) of Regulation EC (No) 726/2004 Nitrosamine impurities in human medicinal products Procedure number: EMEA/H/A-5(3)/1490 Note: Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted. EMA/369136/2020 Page 2/90 Table of contents Table of contents.
Committee for Medicinal Products for Human Use (CHMP) Assessment report . Procedure under Article 5(3) of Regulation EC (No) 726/2004 . Nitrosamine impurities in human medicinal products . Procedure number: EMEA/H/A-5(3)/1490 . Note: Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}